OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2024
(4)
2023
(4)
2022
(4)
2015
(3)
2021
(2)
2020
(2)
2019
(2)
2025
(1)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
A series of medium and high copy number arabinose-inducible Escherichia coli expression vectors compatible with pBR322 and pACYC184.
Not available
S-EPMC4600428
|
biostudies-literature
Cite
Morbidities, health problems, health care seeking and utilization behaviour among elderly residing on urban areas of eastern Nepal: A cross-sectional study.
Not available
S-EPMC9451091
|
biostudies-literature
Cite
Factors associated with self-care behaviours among people with hypertension residing in Kathmandu: a cross-sectional study.
Not available
S-EPMC10314425
|
biostudies-literature
Cite
Risk perception towards healthcare waste among community people in Kathmandu, Nepal.
Not available
S-EPMC7105151
|
biostudies-literature
Cite
Prevalence and determinants of non-communicable disease risk factors among adult population of Kathmandu.
Not available
S-EPMC8425558
|
biostudies-literature
Cite
Factors associated with generalised anxiety disorder and depression among adults living with diabetes and hypertension comorbidity in rural Bangladesh: findings from a cross-sectional study.
Not available
S-EPMC12414191
|
biostudies-literature
Cite
The Complete Genome Sequence of
Cymbopogon citratus
(Poaceae, Poales), Lemon Grass.
Not available
S-EPMC10194061
|
biostudies-literature
Cite
Deciphering a unique biotin scavenging pathway with redundant genes in the probiotic bacterium Lactococcus lactis.
Not available
S-EPMC4861984
|
biostudies-literature
Cite
The repABC Plasmids with Quorum-Regulated Transfer Systems in Members of the Rhizobiales Divide into Two Structurally and Separately Evolving Groups.
Not available
S-EPMC4700958
|
biostudies-literature
Cite
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.
Not available
S-EPMC10469877
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets